He Wang

NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.

F. Zhan, Z. Zeng, W. Xiong, 2013, Cancer cell.

Decreased ferroportin promotes myeloma cell growth and osteoclast differentiation.

F. Zhan, G. Tricot, Ye Yang, 2015, Cancer research.

RARα2 expression confers myeloma stem cell features.

F. Zhan, G. Tricot, Wen Zhou, 2013, Blood.

NEK 2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers

F. Zhan, Z. Zeng, W. Xiong, 2013 .

Phase I Exploratory Study of IV Formulation of Panobinostat in Combination with Bortezomib in Relapsed/Refractory Multiple Myeloma Patients: Effect On Serum PTH and Gene Expression Profiling (GEP) Studies

F. Zhan, M. Salama, Wen Zhou, 2012 .